New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.
作者： Dexin Zhang , Daiming Fan
DOI: 10.2217/FON.10.21
关键词: Cancer treatment 、 Chemotherapy 、 Cancer 、 Targeted therapy 、 Internal medicine 、 Combined use 、 ABCC1 、 Medicine 、 Oncology 、 Multiple drug resistance 、 Treatment options
摘要: Gastric cancer is still the second leading cause of cancer death worldwide. Chemotherapy is one of the major treatment options for advanced gastric cancer. The efficacy of …
futuremedicine.com
sci-hub.se 参考文章(87)
Hong-Gang Yu, Yao-Wei Ai, Liang-Liang Yu, Xiao-Dong Zhou, Jin Liu, Jun-Hua Li, Xi-Ming Xu, Song Liu, Jing Chen, Fen Liu, Yuan-Ling Qi, Quanjun Deng, Jun Cao, Shi-Quan Liu, He-Sheng Luo, Jie-Ping Yu, Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death International Journal of Cancer. ,vol. 122, pp. 433- 443 ,(2008) , 10.1002/IJC.23049
Gary K. Schwartz, Yuhong She, Francis Sirotnak, Carina Rizzo, Monica Motwani, Flavopiridol Enhances the Effect of Docetaxel in Vitro and in Vivo in Human Gastric Cancer Cells1 Molecular Cancer Therapeutics. ,vol. 2, pp. 549- 555 ,(2003)
Jaffer A Ajani, Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel. Expert Opinion on Pharmacotherapy. ,vol. 7, pp. 1627- 1631 ,(2006) , 10.1517/14656566.7.12.1627
P Michl, J Downward, Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Zeitschrift Fur Gastroenterologie. ,vol. 43, pp. 1133- 1139 ,(2005) , 10.1055/S-2005-858638
Yanqiu Zhao, Han You, Fei Liu, Huazhang An, Yongquan Shi, Qiang Yu, Daiming Fan, Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells Cancer Letters. ,vol. 185, pp. 211- 218 ,(2002) , 10.1016/S0304-3835(02)00264-1
Lin Xia, Dexin Zhang, Rui Du, Yanglin Pan, Lina Zhao, Shiren Sun, Liu Hong, Jie Liu, Daiming Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer. ,vol. 123, pp. 372- 379 ,(2008) , 10.1002/IJC.23501
S Rao, N Starling, D Cunningham, M Benson, A Wotherspoon, C Lüpfert, R Kurek, J Oates, J Baselga, A Hill, Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. British Journal of Cancer. ,vol. 99, pp. 868- 874 ,(2008) , 10.1038/SJ.BJC.6604622
SW Han, DY Oh, SA Im, SR Park, KW Lee, HS Song, NS Lee, KH Lee, IS Choi, MH Lee, MA Kim, WH Kim, YJ Bang, TY Kim, None, Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. British Journal of Cancer. ,vol. 100, pp. 298- 304 ,(2009) , 10.1038/SJ.BJC.6604861
Lesley Hutchinson, André Seidel, Hermann Lage, Mary K. Danks, Manfred Dietel, Scott H. Kaufmann, Udo Kellner, Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. International Journal of Cancer. ,vol. 71, pp. 817- 824 ,(1997) , 10.1002/(SICI)1097-0215(19970529)71:5<817::AID-IJC20>3.0.CO;2-3
Eiji Oki, Hideo Baba, Eriko Tokunaga, Toshihiko Nakamura, Naoyuki Ueda, Motonori Futatsugi, Kohjiro Mashino, Manabu Yamamoto, Masahiko Ikebe, Yoshihiro Kakeji, Yoshihiko Maehara, None, Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer International Journal of Cancer. ,vol. 117, pp. 376- 380 ,(2005) , 10.1002/IJC.21170